Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOBETASOL for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 3,133 adverse event reports in the FDA FAERS database where CLOBETASOL was used for Psoriasis.

Most Reported Side Effects for CLOBETASOL

Side Effect Reports % Deaths Hosp.
Drug ineffective 3,217 41.2% 17 109
Psoriasis 1,317 16.9% 1 23
Product use in unapproved indication 706 9.0% 20 52
Pruritus 697 8.9% 0 37
Therapeutic product effect incomplete 643 8.2% 2 26
Skin exfoliation 550 7.1% 0 45
Off label use 540 6.9% 20 79
Treatment failure 535 6.9% 0 12
Erythema 464 5.9% 1 40
Arthralgia 417 5.3% 0 12
Rash 335 4.3% 2 31
Condition aggravated 297 3.8% 4 28
Drug ineffective for unapproved indication 248 3.2% 2 19
Psoriatic arthropathy 240 3.1% 0 2
Papule 234 3.0% 0 2

Other Indications for CLOBETASOL

Product used for unknown indication (1,413) Eczema (304) Psoriatic arthropathy (229) Pemphigoid (225) Pruritus (175) Dermatitis atopic (145) Rash (143) Lichen sclerosus (117) Alopecia (98) Pyoderma gangrenosum (68)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

CLOBETASOL Full Profile All Psoriasis Drugs CLOBETASOL Demographics CLOBETASOL Timeline